Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M

出版年份 2018 全文链接

标题

作者

关键词

Non-small cell lung cancer, Osimertinib, Loss of T790M mutation, Early progression

出版物

Volume 128, Issue -, Pages 33-39

出版商

Elsevier BV

发表日期

2018-12-13

DOI

10.1016/j.lungcan.2018.12.010

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started